Biote Corp. Directors Stack Deferred Equity, Betting on 2027 Growth—Share Price Slides 6% Despite Confidence Play
Biote Corp insiders buy 35,259 RSUs and 130,000 share options, showing confidence in future growth; investors should track vesting, milestones, and market sentiment.
3 minutes to read
